Market Overview

UPDATE: Deutsche Bank Downgrades Albemarle Corporation on Lack of Near Term Catalysts

Related ALB
Which Chemical Company Will Be Hit Hardest By The Supreme Court's Mercury Ruling?
Earnings Scheduled For May 6, 2015
Airgas (ARG) Q1 Earnings Beat, Updates FY16 Guidance - Analyst Blog (Zacks)

Deutsche Bank downgraded Albemarle Corporation (NYSE: ALB) from Buy to Hold and raised the price target from $64.00 to $70.00.

Deutsche Bank noted, "While we see no signs of structural deterioration in Albemarle's core bromine or catalyst franchises (both of which should underpin a return to 10%-plus EPS growth in '14E), we are downgrading Albemarle to Hold from Buy owing to a lack of near-term catalysts as '13 EPS will be back-end loaded and valuation, while not stretched, is nonetheless fair at 13.2x '13E EPS. Most disappointing in the near-term is that Catalysts, which was expected to have a 'step-out' earnings year in '13, is seeing the step shortened due to a number of factors (e.g. less favorable HPC mix, FCC customer turnarounds). With 1H '13E EPS down 17%, YoY, we believe the shares will be range-bound in the near-term.

Albemarle Corporation closed at $64.67 on Wednesday.

Latest Ratings for ALB

Jul 2015BB&T CapitalInitiates Coverage onBuy
Jun 2015Global HunterInitiates Coverage onAccumulate
May 2015CitigroupMaintainsNeutral

View More Analyst Ratings for ALB
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings


Related Articles (ALB)

Get Benzinga's Newsletters